Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2012
08/09/2012US20120204280 Drg11-responsive (dragon) gene family
08/09/2012US20120204279 Polynucleotide derived from novel hepatitis c virus strain and use thereof
08/09/2012US20120204278 Animal models and therapeutic molecules
08/09/2012US20120204277 Non-Aggregating Fluorescent Proteins and Methods for Using the Same
08/09/2012US20120204276 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
08/09/2012US20120204273 Compositions relating to a phosphoprotein and methods of use
08/09/2012US20120203052 Therapeutic regimen for treating cancer
08/09/2012US20120202985 Hyper IgE Animal Model with Enhanced Immunoglobulin Heavy Chain Class Switching to C-epsilon
08/09/2012US20120202981 Novel guanosine-rich modified oligonucleotides and antiproliferative activity thereof
08/09/2012US20120202948 Monodisperse random coil proteins and bioconjugates thereof
08/09/2012US20120202874 Antisense oligonucleotide modulation of stat3 expression
08/09/2012US20120202873 RNAi Probes Targeting Cancer-Related Proteins
08/09/2012US20120202748 Recombinant mussel adhesive protein fp-131
08/09/2012US20120202739 Gdf3 antibodies and related methods
08/09/2012US20120202734 Antibiotic, its nucleotide sequence, methods of construction and uses thereof
08/09/2012US20120202732 Modified aav capsid polypeptides
08/09/2012US20120202714 Conjugate probes and optical detection of analytes
08/09/2012US20120202706 6-0-sulfated polysaccharides and methods of preparation thereof
08/09/2012US20120202295 Materials and methods for assay of anti-hepatitis c virus (hcv) antibodies
08/09/2012US20120202292 Novel method to generate nutritional compounds from microalgae
08/09/2012US20120202291 Simplified basic media for human pluripotent cell culture
08/09/2012US20120202285 Antibodies to il-6 and their uses
08/09/2012US20120202283 Freeze-dried product for introducing nucleic acid, oligonucleic acid or derivative thereof
08/09/2012US20120202271 Method producing an immune response for reducing the risk of developing brucellosis
08/09/2012US20120202270 Producing an immune response for reducing the risk of developing brucellosis
08/09/2012US20120202266 Polypeptides having endoglucanase activity and polynucleotides encoding same
08/09/2012US20120202258 Lige-type transformants for bioconversion of lignin-derived compounds
08/09/2012US20120202251 In vivo assembly of dna via homologous recombination
08/09/2012US20120202249 Production of an intact virus in a mammalian (non-host) cell system using a secondary non-host viral construct
08/09/2012US20120202247 Method, computing routine, device for predicting properties of mhc/peptide complexes, and data and peptides produced therefrom
08/09/2012US20120202246 Vector Comprising Mannose Promoter and Mannose Promoter
08/09/2012US20120202245 Method for Producing Natively Folded Proteins in a Prokaryotic Host
08/09/2012US20120202244 Antibodies Capable of Specifically Binding to a Specific Amino Acid Sequence
08/09/2012US20120202243 IN Vivo Incorporation of Unnatural Amino Acids
08/09/2012US20120202224 Polypeptide variants with altered effector function
08/09/2012US20120202222 Enzyme fragment complementation assays for monitoring the activation of the voltage-gated potassium ion channel herg
08/09/2012US20120202208 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
08/09/2012US20120202206 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
08/09/2012US20120202197 Efficient proliferation method for a kupffer cell and use thereof
08/09/2012US20120201923 Synthetic phytase variants
08/09/2012US20120201848 Isolation of a virus related to canine parvovirus-2 from a raccoon
08/09/2012US20120201844 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/09/2012US20120201843 Cyp1b1 nucleic acids and methods of use
08/09/2012US20120201841 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
08/09/2012US20120201835 Antibodies specific for dkk-1
08/09/2012US20120201829 Human Monoclonal Antibody Against S. Aureus Derived Alpha-Toxin and Its Use in Treating or Preventing Abscess Formation
08/09/2012US20120201827 Anti-cd38 antibodies
08/09/2012US20120201825 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
08/09/2012US20120201824 Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity
08/09/2012US20120201811 Generation and use of fab, scfv, and related binding molecules specific for hiv-1 rev
08/09/2012US20120201807 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
08/09/2012US20120201794 Dual vector for inhibition of human immunodeficiency virus
08/09/2012US20120201792 Methods and products for manipulating hematopoietic stem cells
08/09/2012US20120201790 Promoters exhibiting endothelial cell specificity and methods of using same
08/09/2012US20120201788 Methods and compositions for cell therapy
08/09/2012US20120199144 Transgenic Plants
08/09/2012DE112010002353T5 Neue fettsäure-elongations-komponenten und anwenduingen davon New-fatty acid elongation and components thereof anwenduingen
08/09/2012DE102010013166B4 Verfahren zur Erhöhung des Samenertrages sowie Förderung des Wachstums von Pflanzen A method for increasing seed yield and promoting the growth of plants
08/09/2012DE10113776B4 Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins An isolated streptavidinbindendes competitively elutable peptide, this complete fusion peptide, nucleic acid coding therefor, expression vector, to methods for producing a recombinant fusion protein, and methods for the detection and / or for the recovery of the fusion protein
08/09/2012CA2826594A1 Multivalent vaccines for rabies virus and filoviruses
08/09/2012CA2826579A1 Peptide library
08/09/2012CA2826554A1 Methods of developing terpene synthase variants
08/09/2012CA2826293A1 Microorganisms and methods for the biosynthesis of butadiene
08/09/2012CA2826284A1 Acetyl co-enzyme a carboxylase herbicide resistant plants
08/09/2012CA2826254A1 Compositions and methods for controlling carbon dioxide- (co2-) regulated stomatal apertures, water transpiration and water use efficiency in plants
08/09/2012CA2826142A1 Methods and materials for enhancing functional protein expression in bacteria
08/09/2012CA2826131A1 Massively parallel continguity mapping
08/09/2012CA2826111A1 Methods for enriching microparticles or nucleic acids in a complex mixture using size exclusion filtration
08/09/2012CA2826043A1 Synthetic mimics of mir-124
08/09/2012CA2825994A1 Efficient sterilization of fish by disruption of germ cell development
08/09/2012CA2825981A1 Synthetic mimics of mir-34
08/09/2012CA2825691A1 Tailored oils produced from recombinant oleaginous microorganisms
08/09/2012CA2825151A1 Methods of nucleic acid quantification and detection using anomalous migration
08/09/2012CA2824671A1 Method to develop high oleic acid soybeans using conventional soybean breeding techniques
08/09/2012CA2821622A1 Pharmaceutical composition consisting of rna having alkali metal as counter ion and formulated with dications
08/09/2012CA2821355A1 Methods for enriching microparticles or nucleic acids using binding molecules
08/08/2012EP2484777A1 Gene expression profiling from FFPE samples
08/08/2012EP2484774A2 Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
08/08/2012EP2484773A2 Process for producing anthocyanins
08/08/2012EP2484772A1 Methods for dynamic vector assembly of DNA cloning vector plasmids
08/08/2012EP2484770A1 Complexes of RNA and cationic peptides for transfection and for immunostimulation
08/08/2012EP2484769A2 Transgenic plants with enhanced agronomic traits
08/08/2012EP2484768A2 Mucosal or enteral administration of biologically active macromolecules
08/08/2012EP2484767A1 Novel Herbicide resistance genes
08/08/2012EP2484766A1 Method for producing a target protein connected with a heterogeneous ferritin protein using yeast host cells
08/08/2012EP2484765A1 Cell transfection under rab37 deficiency or inhibition
08/08/2012EP2484764A1 Enhanced amylase production by N-terminal addition to mature amylase protein
08/08/2012EP2484763A2 Neukinase, a downstream protein of neuregulin
08/08/2012EP2484762A1 Method for predicting therapeutic effect of immunotherapy on cancer patient and/or prognosis after immunotherapy, and gene set and kit to be used therein
08/08/2012EP2484761A1 Dna construct, and process for production of recombinant cho cell using same
08/08/2012EP2484760A1 METHOD FOR PREPARING aRNA AND METHOD FOR ASSAYING GENE EXPRESSION
08/08/2012EP2484759A2 Methods of refolding mammalian glycosyltransferases
08/08/2012EP2484758A1 Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
08/08/2012EP2484757A1 Virus capable of expressing -galactose epitope, and method for production of vaccine
08/08/2012EP2484751A2 Gradient structures interfacing microfluidics and nanofluidics, methods for fabrication and uses thereof
08/08/2012EP2484698A1 Hybridoma producing anti-methylated dna antibody and utilization of same
08/08/2012EP2484696A1 Antagonistic human light-specific human monoclonal antibodies
08/08/2012EP2484694A1 Monoclonal antibody against human hig-1 polypeptide
08/08/2012EP2484693A1 Human serum amyloid-a3 antibody and use thereof
08/08/2012EP2484691A1 TNF superfamily collectin fusion proteins